☰ Menu

2021 Conference Programme

DAY ONE | THURSDAY 18 NOVEMBER

12.30

Welcome and introduction
Dr Fiona McDonald, Clinical Consultant Oncologist, The Royal Marsden NHS Foundation Trust & Chair, UK SABR Consortium

12.40

Sponsored session
Speaker tba

13.10

Treatment plan optimisation for re-irradiation
Dr Louise Murray, Yorkshire Cancer Research University Clinical Academic Fellow and Honorary Consultant Clinical Oncologist

13.40

Prostate SBRT – through PACE to HERMES
Dr Alison Tree, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust

14.10

Comfort break and poster viewing

14.30

Spine SABR – results from SC24 and future directions in treatments
Professor Zain Husain, Clinician Investigator, Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto

15.00

Sponsored session
Speaker tba

15.30

Proferred papers in spotlight

16.30

Close of day

DAY TWO | FRIDAY 19 NOVEMBER

09.30

Welcome and introduction
Chris Dean, Lead Stereotactic Radiotherapy Physicist, Barts Health NHS Trust & Vice-Chair,
UK SABR Consortium

09.40

Keynote address: Pancreatic SABR – overview of treatment, what experience has taught us and what’s next?
Dr Dominique Lee, Consultant Radiation Oncologist, Princess Alexandra Hospital, Icon Cancer Centre, Brisbane, Australia

10.10

Session tba

10.40

Mentor and mentee perspectives of introducing SABR for oligometastases
SABR Team, Guy’s and St Thomas’ NHS Foundation Trust and SABR Team, Kent Oncology Centre

11.10

Comfort break and poster viewing

11.30

Sponsored session
Speaker tba

12.00

Updates and insights on the SABR expansion programme
Patricia Diez
, Lead Clinical Scientist, Mount Vernon Cancer Centre, National Radiotherapy Trials Quality Assurance (RTTQA) Group
Rushil Patel, Lead SABR Physicist, Mount Vernon Cancer Centre, National Radiotherapy Trials Quality Assurance (RTTQA) Group

12.30

Comfort break and poster viewing

13.00

Proferred papers in the spotlight

14.00

GTV-based prescription in SBRT for lung lesions
Thomas Lacornerie, Medical Physicist, Centre Oscar Lambert, Lille, France

14.30

Clinical lung cases – what to treat and what not to treat?
Chair: Dr Clive Peedell, Consultant Clinical Oncologist, South Tees NHS Trust
Dr Nicolaus Andratschke, Oncologist, University Hospital of Zurich, Switzerland,
Dr Kevin N Franks, Consultant Clinical Oncologist, Leeds Teaching Hospitals NHS Trust
Dr Fiona McDonald, Clinical Consultant Oncologist, The Royal Marsden NHS Foundation Trust
Dr Brendon Stiles, Chief of Thoracic Surgery and Surgical Oncology and Associate Director of Surgical Services for the Montefiore-Einstein Cancer Center, New York City

15.30

Closing remarks
Dr Fiona McDonald, Clinical Consultant Oncologist, The Royal Marsden NHS Foundation Trust & Chair, UK SABR Consortium